The following are appropriate:

At the start of therapy, measure plasma ammonia concentration at least every two weeks (or more often depending on the stability of the affected individual), then slowly extend to every month, every two months, every three months, and every four months, as possible.

At the start of therapy, perform plasma amino acid (PAA) analysis at least every two weeks (or more often depending on the stability of the affected individual), then slowly extend to every month, every two months, every three months, and every four months.

Perform liver function tests depending on symptoms every three to six months or more often if they have been previously elevated.

Perform neuropsychological testing at the time that significant developmental milestones are expected to be achieved (e.g., at 6-9 months, 18 months, 3 years)
